Natural killer cells in COVID-19: from infection, to vaccination and therapy

Author:

Zafarani Alireza1ORCID,Razizadeh Mohammad Hossein2ORCID,Pashangzadeh Salar34ORCID,Amirzargar Mohammad Reza1ORCID,Taghavi-Farahabadi Mahsa5ORCID,Mahmoudi Mohammad6ORCID

Affiliation:

1. Department of Hematology & Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

2. Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

3. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran

4. Immunology Today, Universal Scientific Education & Research Network (USERN), Tehran, Iran

5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

6. Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran

Abstract

Natural killer (NK) cells are among the most important innate immunity members, which are the first cells that fight against infected cells. The function of these cells is impaired in patients with COVID-19 and they are not able to prevent the spread of the disease or destroy the infected cells. Few studies have evaluated the effects of COVID-19 vaccines on NK cells, though it has been demonstrated that DNA vaccines and BNT162b2 can affect NK cell response. In the present paper, the effects of SARS-CoV-2 on the NK cells during infection, the effect of vaccination on NK cells, and the NK cell-based therapies were reviewed.

Publisher

Future Medicine Ltd

Subject

Virology

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3